Squeezing a dynamometer for three seconds tells you more about your health than almost any other test that fits in one hand. Grip strength predicts death, heart disease and dementia across millions of people, in dozens of countries, over decades of follow-up. It is cheap, quick and unglamorous — and it deserves your attention.
Here is what the evidence says about what grip strength measures, what counts as low, how to improve it, and where it fits alongside the marker that still matters most for longevity.
What grip strength actually measures
Grip strength is the maximum force your hand can generate, measured in kilograms with a hand dynamometer. You squeeze as hard as you can for a few seconds; the best of two or three attempts is recorded.
What makes it useful is that it is not really about your hands. Grip strength is a reliable proxy for whole-body muscular strength and, more broadly, for the integrity of the neuromuscular system — motor unit recruitment, muscle quality and the nervous system’s ability to drive them. That is why a test of one muscle group carries information about the whole organism.
It also tracks a predictable arc across life. In 200,389 German adults aged 19 to 75, grip strength rose through the third and fourth decades, peaked around the age of 40, and declined steadily thereafter (Huemer et al., 2023). If you are over 40, your grip is almost certainly declining. The question is how fast.
Why grip strength predicts how long you live
The landmark evidence comes from the Prospective Urban Rural Epidemiology (PURE) study, which followed 139,691 adults across 17 countries. Each 5 kg reduction in grip strength was associated with a 16% higher risk of death from any cause (hazard ratio 1.16, 95% CI 1.13–1.20). Notably, grip strength was a stronger predictor of all-cause and cardiovascular mortality than systolic blood pressure (Leong et al., 2015).
That finding has held up at scale. A meta-analysis pooling 42 prospective cohort studies and 3,002,203 participants found that each 5 kg lower grip strength was associated with a 16% higher risk of all-cause mortality, a 21% higher risk of cardiovascular disease, a 9% higher risk of stroke and a 7% higher risk of coronary heart disease. The association with cancer was not significant (Wu et al., 2017).
The signal extends to the brain. Among 466,788 UK Biobank participants followed for a mean of 9.1 years, those in the lowest fifth for grip strength had a 72% higher risk of developing dementia and an 87% higher risk of dying from it, compared with those in the highest fifth (Esteban-Cornejo et al., 2022).
One caveat matters, and it matters a great deal. These are observational associations. Weak grip is a marker of underlying frailty, illness and inactivity as much as a cause of poor outcomes — and no trial has yet shown that training your grip in isolation extends life. Treat grip strength as a diagnostic reading, not a lever you pull.
What counts as low grip strength?
The most widely used clinical thresholds come from the revised European consensus on sarcopenia, which defines low grip strength as below 27 kg for men and below 16 kg for women (Cruz-Jentoft et al., 2019). These are deliberately conservative cut-offs, designed to flag clinically meaningful muscle weakness rather than to describe average fitness.
Population data suggest they may be set low. Working from the German National Cohort, researchers derived cut-off points of 29 kg for men and 18 kg for women — and when applied to an older German cohort, those thresholds identified roughly 1.5 times as many people with low grip strength as the European criteria did (17.7% versus 11.7%) (Huemer et al., 2023).
The practical implication: clearing the clinical threshold is a floor, not a target. Individual variation is wide, and a single reading tells you less than a series of readings does. Measure yourself, note the number, and measure again in six months. The trajectory is the information.
How to improve grip strength
Grip strength responds to training, and the dose has been mapped reasonably well. A Bayesian network meta-analysis of 13 randomised trials in 711 older adults (mean age 68.3 years) with sarcopenia identified an optimal resistance-training prescription of three sessions per week, at roughly 49% of one-repetition maximum, sustained for around 19 weeks. Effective doses ranged from two to five sessions per week at 30–75% of 1RM over 4 to 24 weeks (Li et al., 2025).
Two things stand out in that data. First, the intensities are moderate — this is not a case where only maximal effort works. Second, the timescale is months, not weeks. Four weeks is the lower bound for a measurable change; 19 weeks is where the effect was largest.
In practice, the movements that build grip are the ones that make you hold something heavy for time:
- Loaded carries. Walk 30–60 metres holding a heavy weight in each hand. Simple, scalable and hard to do badly.
- Dead hangs. Hang from a bar for as long as you can hold. Build to 30–60 seconds.
- Pulling movements. Rows and deadlifts train grip as a by-product, provided you avoid straps.
- Isometric holds. Squeeze a dynamometer or gripper at a sub-maximal effort for two minutes, repeated four times.
That last one has an unexpected side benefit. A meta-analysis of nine randomised controlled trials found that isometric handgrip training reduced resting systolic blood pressure by 6.7 mmHg (95% CI −10.3 to −3.4) and diastolic pressure by 4.5 mmHg (95% CI −7.3 to −1.7) in people with hypertension. A single session did nothing — the effect required sustained training (Oliveira et al., 2023).
Grip strength is not a substitute for cardiorespiratory fitness
It would be easy to read the mortality data and conclude that strength is the thing to chase. The evidence does not support that reading.
When cardiorespiratory fitness and grip strength were measured in the same 70,913 UK Biobank adults and followed for 5.7 years, both carried independent information — but fitness did the heavier lifting. Compared with the least fit group, those in the highest fitness category had a 35% lower risk of death from any cause (hazard ratio 0.65), even after adjusting for grip strength (Kim et al., 2018).
This is why VO₂max — your maximal oxygen uptake, the ceiling on how much oxygen your body can use during intense exercise — remains the single most important health marker CAROL is built around. Grip strength is the useful second reading, not the replacement.
The two are also trained differently, and neither trains the other. REHIT (Reduced Exertion High-Intensity Interval Training), CAROL’s signature workout, raises VO₂max through two 20-second all-out sprints inside a session of about five minutes. It will not build your grip. A weekly resistance session will not raise your VO₂max meaningfully either. If you want both markers moving in the right direction, you need both stimuli.
The bottom line
Grip strength is one of the cheapest, fastest and most informative measurements in health. Each 5 kg below the average is associated with a 16% higher risk of death across more than three million people, and the signal extends to cardiovascular disease and dementia. Low is defined clinically as under 27 kg for men and 16 kg for women, though population data suggest slightly higher thresholds are more realistic.
To improve it, train resistance two to five times a week at moderate intensity for at least four months, and favour movements that ask you to hold load — carries, hangs, rows, deadlifts. Isometric holds add a modest blood pressure benefit on top.
But keep the hierarchy straight. Grip strength is a marker of how well you are ageing, not a mechanism you can train your way past. The evidence still points to cardiorespiratory fitness as the primary lever. Measure your grip, track it, train it — and keep your VO₂max at the centre of the programme.
